SecSonar.com

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Indivior Pharmaceuticals Inc (INDV) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $4.5B. Revenue grew 4.3% year-over-year and free cash flow was negative at -$93M. This page tracks INDV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.03K employees · IPO Dec 29, 2014

Valuation

Valuation & price

$36.76 · as of May 17, 2026 · -12.1% vs 52w high

22.4

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$41.83$28.48$15.14Jul 25Dec 25Jul 26Jul 7, 25$15.55Jul 9, 25$15.14Jul 11, 25$15.47Jul 15, 25$15.38Jul 17, 25$16.16Jul 21, 25$15.60Jul 23, 25$16.95Jul 25, 25$17.14Jul 29, 25$17.28Jul 31, 25$20.20Aug 4, 25$21.22Aug 6, 25$22.00Aug 11, 25$22.29Aug 13, 25$22.97Aug 15, 25$23.46Aug 19, 25$23.48Aug 21, 25$24.05Aug 25, 25$24.01Aug 27, 25$24.36Aug 29, 25$24.28Sep 3, 25$24.67Sep 5, 25$24.98Sep 9, 25$24.66Sep 11, 25$23.88Sep 16, 25$22.77Sep 18, 25$22.89Sep 22, 25$23.27Sep 24, 25$22.85Sep 26, 25$23.92Sep 30, 25$24.11Oct 2, 25$23.26Oct 6, 25$22.73Oct 8, 25$24.07Oct 10, 25$23.78Oct 14, 25$24.54Oct 16, 25$24.69Oct 21, 25$24.09Oct 23, 25$25.28Oct 27, 25$24.78Oct 29, 25$25.24Oct 31, 25$29.37Nov 4, 25$32.00Nov 6, 25$31.87Nov 10, 25$30.88Nov 12, 25$30.10Nov 14, 25$30.49Nov 18, 25$32.26Nov 20, 25$31.77Nov 25, 25$33.10Nov 28, 25$33.60Dec 2, 25$34.00Dec 4, 25$34.60Dec 8, 25$36.60Dec 10, 25$35.45Dec 12, 25$35.56Dec 16, 25$35.38Dec 18, 25$35.54Dec 22, 25$36.45Dec 24, 25$36.16Dec 29, 25$36.35Jan 2, 26$35.73Jan 6, 26$36.19Jan 8, 26$35.51Jan 12, 26$34.56Jan 14, 26$33.63Jan 16, 26$32.54Jan 21, 26$32.98Jan 23, 26$32.97Jan 27, 26$34.74Jan 29, 26$34.71Feb 2, 26$35.00Feb 4, 26$34.34Feb 9, 26$33.86Feb 11, 26$34.08Feb 13, 26$34.58Feb 18, 26$34.36Feb 20, 26$33.89Feb 24, 26$33.06Feb 26, 26$33.71Mar 2, 26$31.98Mar 4, 26$32.16Mar 6, 26$32.27Mar 10, 26$33.34Mar 12, 26$30.86Mar 17, 26$31.33Mar 19, 26$30.50Mar 23, 26$29.39Mar 25, 26$30.26Mar 27, 26$28.97Mar 31, 26$30.48Apr 2, 26$30.47Apr 7, 26$30.47Apr 9, 26$32.31Apr 13, 26$31.60Apr 15, 26$32.52Apr 17, 26$32.70Apr 22, 26$33.39Apr 24, 26$33.23Apr 28, 26$34.43Apr 30, 26$36.78May 4, 26$38.98May 6, 26$40.61May 8, 26$39.50May 12, 26$38.28May 14, 26$37.83May 18, 26$36.54May 20, 26$37.59May 22, 26$37.53May 28, 26$36.61Jun 1, 26$34.88Jun 3, 26$35.43Jun 5, 26$37.62Jun 9, 26$38.26Jun 11, 26$38.13Jun 15, 26$38.40Jun 17, 26$37.93Jun 22, 26$38.32Jun 24, 26$41.47Jun 26, 26$41.83Jul 2, 26$40.06
$15.1452-week range$41.83
Loading valuation history…

Fundamentals

Key fundamentals

$4.5B

Market cap

4.3%

Revenue growth (YoY)

80.2%

Gross margin

-$93M

Free cash flow (USD)

$156M

Net debt

-5.3%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$968.9MFY 2017$1.1BFY 2018$959.9MFY 2019$785.0MFY 2020$647.0MFY 2021$791.0MFY 2022$901.0MFY 2023$1.1BFY 2024$1.2BFY 2025$1.2B
$968.9M$1.2B

Free cash flow by year

2016 → 2025

FY 2016$340.7MFY 2017$264.7MFY 2018$250.2MFY 2019$144.0MFY 2020$-197.0MFY 2021$319.0MFY 2022$-9.0MFY 2023$-353.0MFY 2024$7.0MFY 2025$-93.0M
$340.7M-$93M

Gross margin by year

2021 → 2025

FY 202183.9%FY 202283.2%FY 202384.1%FY 202480.6%FY 202580.2%
83.9%80.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventChief Scientific Officer EliminationMay 15, 2026Filing
  • 8-K eventShare RepurchaseMay 4, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is Indivior Pharmaceuticals Inc's market cap?

Indivior Pharmaceuticals Inc (INDV) has a market capitalization of $4.5B.

What is INDV's P/E ratio?

INDV trades at a price-to-earnings ratio of 22.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying INDV stock?

SEC Form 4 filings show no open-market insider buys at Indivior Pharmaceuticals Inc in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

AMRX

Amneal Pharmaceuticals, Inc.

$4.2B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

LNTH

Lantheus Holdings, Inc.

$6.5B

HCM

HUTCHMED (China) Limited

$2B

BHC

Bausch Health Companies Inc.

$2B

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.